招聘
Sarepta
Sarepta
Genetic medicine company
Gene Therapy
Drug Development
Clinical Research
Molecular Biology
Biostatistics
开放职位
0个职位
目前没有开放的职位
产品与服务
EL
ELEVIDYS
Gene Therapy
ELEVIDYS
Gene Therapy
EXONDYS 51
Antisense Oligonucleotide
EX
EXONDYS 51
RNA-targeted Therapy
VYONDYS 53
Antisense Oligonucleotide
VY
VYONDYS 53
RNA-targeted Therapy
AMONDYS 45
Antisense Oligonucleotide
AM
AMONDYS 45
RNA-targeted Therapy
VILTEPSO
Antisense Oligonucleotide
SR
SRP-9001
Gene Therapy
CA
CASIMERSEN
RNA-targeted Therapy
SRP-9001
Gene Therapy
Limb-girdle muscular dystrophy programs
Gene Therapy
LI
Limb-girdle Muscular Dystrophy Programs
Gene Therapy
RNA-targeted therapeutics platform
Platform Technology
CH
Charcot-Marie-Tooth Disease Programs
Neuromuscular Therapy
相似公司
Regeneron
Public
Focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations int...
Westchester County, New York
10,001+
Valuation $76B
422 open jobs
Biogen
Public
Specializing in the treatment of neurological diseases.
Cambridge, Massachusetts
5,001-10,000
Valuation $16.2B
259 open jobs
Abbott
Public
Global healthcare company creating breakthrough diagnostics and devices
Abbott Park, Illinois
10,001+
Valuation $177B
1867 open jobs
Pfizer
Public
Breakthroughs that change patients' lives.
New York City, New York
10,001+
Valuation $280B
138 open jobs
Johnson & Johnson
Public
Caring for the world, one person at a time.
New Brunswick, New Jersey
10000+
Valuation $400B
1618 open jobs
Vertex
Biopharmaceutical company.
Boston, Massachusetts
新闻动态
All
X
News
HN
YouTube
H.C. Wainwright reiterates Sarepta stock Sell rating at $5 target - Investing.com
Investing.com
News
·
4天前
Will Roche’s New Global Elevidys Phase 3 Trial Shift Sarepta Therapeutics' (SRPT) Gene Therapy Narrative? - simplywall.st
simplywall.st
News
·
4天前
Sarepta/ Roche Duchenne therapy to face new late-stage trial targeting EU nod - Seeking Alpha
Seeking Alpha
News
·
5天前
Roche to start new Elevidys study following setback in Europe - BioPharma Dive
BioPharma Dive
News
·
5天前
Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy - Fierce Pharma
Fierce Pharma
News
·
5天前
更多 (剩余15条)
总浏览量
0
申请点击数
0
模拟申请者数
0
收藏
0
评价
3.8
48条评价
工作生活平衡
3.5
薪酬
3.9
企业文化
4.0
职业发展
4.0
管理层
3.6
76%
推荐给朋友
优点
Good work-life balance and flexible environment
Supportive team and management
Competitive compensation and benefits
缺点
Some organizational bureaucracy
Room for improvement in processes
Work-life balance varies by team
薪资范围
47个数据点
Director
Mid/L4
Senior/L5
Director
3份报告
$243,750
年薪总额
基本工资
$187,500
股票
-
$240,500
$247,000
面试经验
5次面试
难度
2.2
/ 5
时长
2-5w
录用率
40%
体验
正面 60%
中性 20%
负面 20%
面试流程
1
Application Review
2
HR/Recruiter Screen
3
Technical/Phone Screen
4
Hiring Manager Interview
5
Panel/Onsite Interviews
6
Offer
联系方式与地址